OR PDAB 2025 Drug Review Timeline

	A	B	C	D	E	F	G	H
1	OR PDAB 2025 Drug Review Timeline
2
3	Action	Jun 18 Affordability Review	Jul 16 Affordability Review	Aug 20 Affordability Review	Sep 17 Afforability Review	Oct 15 Affordability Review	Nov 19 Afforability Review	Dec 17 Affordability Review
4
5	Drug Subset	Finalized List for Review	Vraylar Entresto Ajovy Emgality Nurtec Ubrelvy Drug Review Document	Trelegy Eliquis Xarelto Cosentyx Creon Drug Review Document	Jardiance Mounjaro Ozempic Rybelsus Trulicity Drug Review Document
6
7	Insulin Subset	Finalized List for Review				Basaglar KwikPen Insulin Glardine-yfgn Lantus Lantus SolorStar Semglee (yfgn) Toujeo Max SolorStar Toujeo Solostar Drug Review Document
8
9	Annual Report						Reveiw findings	Review findings
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100